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Langerhans cells (LCs) reside in the epidermis where they are poised to mount an
antimicrobial response against microbial pathogens invading from the outside
environment. To elucidate potential pathways by which LCs contribute to host defense,
we mined published LC transcriptomes deposited in GEO and the scientific literature for
genes that participate in antimicrobial responses. Overall, we identified 31 genes in LCs
that encode proteins that contribute to antimicrobial activity, ten of which were cross-
validated in at least two separate experiments. Seven of these ten antimicrobial genes
encode chemokines, CCL1, CCL17, CCL19, CCL2, CCL22, CXCL14 and CXCL2, which
mediate both antimicrobial and inflammatory responses. Of these, CCL22 was detected
in seven of nine transcriptomes and by PCR in cultured LCs. Overall, the antimicrobial
genes identified in LCs encode proteins with broad antibacterial activity, including against
Staphylococcus aureus, which is the leading cause of skin infections. Thus, this study
illustrates that LCs, consistent with their anatomical location, are programmed to mount
an antimicrobial response against invading pathogens in skin.
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INTRODUCTION
Dendritic cells (DCs) are the key antigen presenting cells (APCs) that control both immunity and
tolerance (1). DCs are localized in most tissues and surface barriers, where they function as sentinels
for pathogen recognition. Stimulation of innate signaling receptors induce DCs to migrate from the
periphery to secondary lymphoid organs, where they present antigens that drive adaptive immunity.
DCs are divided into distinct subsets characterized by their unique expression of surface receptors
and transcription factors, pathogen sensors and cytokines secretion profiles that contribute to their
specialized capacities in activating different modules of immunity (2–6).
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Human skin harbors multiple types of dendritic-appearing cells
including Langerhans cells (LCs) that exclusively reside in the
epidermis as well as conventional DCs (cDCs) in the underlying
dermis. In addition to their localization to the epidermis, LCs are
distinguished by their high expression of CD1a, the C-type lectin
langerin (CD207) which induces the formation of a LC-specific
organelle, the Birbeck granule, and lower expression of CD11c than
dermal DCs (7). Through their dendrites, they form an extensive
cellular network patrol the interface between the skin and the
outside environment for pathogens (8–10), bind microbial ligands
via toll-like receptors (TLRs) and CD207 and taking up pathogens
via endocytosis (11–13).
LCs, although derived in mice from similar precursors as
macrophages, have antigen presentation capacities similar to
DCs (14, 15). Upon antigen capture, LCs undergo phenotypic
changes during maturation and migrate to regional lymph nodes
where they activate adaptive responses (12, 16–18). During
infection, LC emigration from the epidermis is significantly
enhanced by inflammatory cytokines such as IL-1 and TNF (19,
20). Migrating LCs express the DC-specific transcription factor
ZBTB46 (21, 22), IL-15 (23) and IRF4, which is important for their
ability to prime and cross-present antigens to CD8+ T cells at that
site (24, 25). Additionally, LCs enhances cellular immunity by
inducing Th1 and Th2 differentiation of CD4+ T cells (3, 4), they
are the main skin DC subset responsible for directing IL-17 and
IL-22-mediated responses (12, 26, 27), indicative of skin
inflammatory and antimicrobial diseases. A subset of migratory
LCs express CD5 with an even greater capacity to amplify these T
cell responses (6). Moreover, a unique aspect of human LC is their
ability to present antigen via CD1a both autoreactive (28, 29) and
Mycobacterium leprae- and M. tuberculosis-reactive CD1a-
restricted T cell responses have been reported (30).
Although it has been previously shown that LCs contribute to
cutaneous host defense against pathogens including viruses (13,
31, 32), bacteria and fungi (33), only a few genes have been
identified that directly mediate the antimicrobial response. In
order to more broadly define the mechanisms by which LCs
potentially contribute to an antimicrobial response, we mined
public LC transcriptomes and surveyed the literature to identify
“antimicrobial genes”, defined as genes encoding proteins with
direct antimicrobial activity.
MATERIALS AND METHODS
Gene Expression Omnibus (GEO) Analysis
We surveyed Gene Expression Omnibus (GEO) (34) for
transcriptomes of human skin-derived LCs and Langerhans-
like dendritic cells (LCDCs), which are derived from CD34+
stem cells, using the key terms “(Langerhans AND skin) AND
Homo sapiens[Organism]”. Our search was for the period before
August 2020 and include those studies in which the LCs were
activated with pro-inflammatory stimuli and/or as compared to
other myeloid populations. This search yielded 24 series, nine of
which met the criteria that n ≥ 3 samples for the LC and
comparison group and did not contain only Langerhans cell
histiocytosis samples. We then used GEO2R, an R-based web
application, to obtain a list of genes that were differentially
expressed in LCs. After obtaining the list of genes, we then
filtered the comparisons by logFC>1 and adj. p-value<0.05. Of
the nine series which the described criteria, one (GSE32648) did
not yield any recognizable gene names on GEO2R and therefore
we contacted the authors who provided us with their new RNA-
seq data instead of the microarray data currently deposited in
GEO2R and for a second dataset (GSE120386), GEO2R was not
available. We used DESeq2 to run differential expression analysis
of both of the bulk RNA-seq data with the default parameters.
Genes with an adj. p value <0.05 were considered significantly
differentially expressed.
LC Antimicrobial Genes
We curated our direct antimicrobial list based on the 105
antimicrobial peptides listed in the Antimicrobial Peptide
Database (APD) (35). The criteria for data registration into
APD are the following: the peptides must be from natural
sources, their antimicrobial activities must have been
demonstrated (MIC <100 ug/ml), and their amino acid
sequences elucidated. We also supplemented this list with
literature findings of eight genes encoding peptides with direct
antimicrobial activity not yet registered into the database including
CCL2 (36), CCL14, CCL15 (37), CXCL7 (38), CXCL17 (39),
MPEG1 (40), S1008A (41), and S1009A (42) yielding a total of
113 genes. To identify which genes encoded peptides with direct
antimicrobial activity, we overlapped the results with our curated
direct antimicrobial list using Venny 2.1 (43).
We also reviewed the literature for direct antimicrobial genes
using the key terms “(Langerhans [Title/Abstract]) AND
(antimicrobial [Title/Abstract])” which yielded 40 results of
which five studies contained evidence for eight genes encoding
peptides with direct antimicrobial activity in LCs. Our search
“(Langerhans [Title/Abstract]) AND (antibacterial [Title/
Abstract])” yielded 21 results, none of which included genes
encoding peptides with direct antimicrobial in LCs.
Ingenuity Pathway Analysis (IPA)
Upstream Regulator Prediction
IPA Upstream Regulator Analysis was used to identify upstream
regulators and predict whether they are activated or inhibited,
given the observed gene expression changes in our experimental
dataset. The analysis examines the known targets of each
upstream regulator in a dataset, compares the targets’ actual
direction of change to expectations derived from the literature,
then generates a prediction for each upstream regulator. Briefly,
IPA uses an ‘enrichment’ score [Fisher’s exact test (FET) P-
value] that measures the overlap of observed and predicted
regulated gene sets.
RESULTS
Identification and Characteristics of
Langerhans Cells Transcriptomes
To identify potential mechanisms by which LCs mount an
antimicrobial response, we queried GEO and identified seven
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microarray series that permitted the mining of the LC
transcriptome data using GEO2R. In addition, there was one
bulk RNA-seq series for which GEO2R was not available
(GSE120386) and another bulk-RNA seq data series not yet
deposited in GEO2R and therefore we used DESeq2 on RStudio
to compute the differential gene expression for both data series
(Supplementary Table S1).
In three of nine series, LCs were directly isolated from skin
specimens by enzymatic digestion, and the transcriptomes
measured immediately. In one study, CD11c+ DDCs were
directly isolated from skin and monocyte derived DCs and
CD1c+ DCs from blood (44). In another study, plasmacytoid
DCs (pDCs) and myeloid DCs (mDCs) were isolated from
peripheral blood (45), and in the third study, pDCs were
isolated from spleen and dermal macrophages from skin (46).
Five of the nine transcriptomes were derived from LCs isolated
by migration, in order to represent those LCs that are in the
process of migration to lymph nodes, albeit this leads to
an altered phenotype. In one study each, CD14+ DCs and
CD14+ macrophages (47), or CD141+ dermal DCs, CD14+
dermal DCs, and CD141-CD14- dermal DCs (21), or dermal
langerin- type 2 conventional dendritic cell (cDC2), dermal
langerin+ cDC2, dermal CD14+CD1c- monocyte-derived
macrophages, and dermal CD14+CD1c+ monocyte-derived
dendritic cells (48) were isolated from skin by enzymatic
digestion. In two of the migratory LC studies, the LC
transcriptomes were measured at time zero and various
timepoints following stimulation by TNF at (24, 49). In the
same transcriptome, CD11c+ dermal DCs were also isolated by
migration (49). In the last series, Langerhans-like dendritic cells
(LCDCs) were generated in vitro and infected with the live
mosquito-derived third-stage larvae (L3) of the parasitic
nematode Brugia malayi (50).
Identification of Antimicrobial Genes
in LCs
We mined the LC transcriptomes by comparing either LCs to
another myeloid cell type or a specific time point following
stimulation. We filtered the comparisons by logFC>1 and
adjusted p-value <0.05, then overlapped the results with the
direct antimicrobial gene list consisting of 113 genes using
Venny 2.1 (43). Using this approach, we identified 23 genes
encoding proteins with direct antimicrobial activity in the LC
transcriptomes (Table 1). Of these 23 genes, 11 were uniquely
identified in LCs isolated by migration (then either
unstimulated or cytokine activated), nine were uniquely
identified in LCs derived from digested skin samples and
three were presented in LCs isolated by migration as well as
from digested skin samples. Although there were more genes
identified in LCs obtained by migration from skin samples as
compared to digested skin samples, as LCs isolated by
enzymatic digestion are immature compared to those isolated
by migration which are in a mature state, and that the migrated
LCs were sometimes activated with cytokines whereas the
digested LCs were not (55).
Antimicrobial Genes Upregulated in
Activated LCs and in LCs Compared to
Other Cell Types
We examined the transcriptomes of LCs activated in vitro by
cytokines or microbes. We identified eight genes that
encode proteins with direct antimicrobial activity by mining
the two transcriptomes of TNF-activated migratory LCs
(Transcriptomes 4 and 7), this was the greatest number in any
of the comparisons performed (Supplementary Table S2).
There were six genes encoding chemokines that were
upregulated in migratory LCs after stimulation with TNF:
CCL1, CCL2, CCL17, CCL19, CCL20, and CXCL2. In addition,
we detected two other genes, ADM and IL26 in LCs stimulated
with TNF (Figure 1). Of the eight total genes, CCL2, CCL19 and
ADM were detected in both transcriptomes of TNF treated LCs.
We did not identify any genes encoding peptides with direct
antimicrobial genes upregulated in LCs stimulated with live
mosquito-derived third-stage larvae (L3) of B. malayi, which is
consistent with the previous finding that the live mosquito-
derived third-stage larvae (L3) fails to activate LCs compared to
known activators (50). By analyzing the comparisons of LCs to
other cell types, we identified 16 antimicrobial genes, of which
only ADM was identified in the transcriptomes of TNF
treated LCs.
We found nine studies in which the LC transcriptome was
compared to other DC subtypes, including dermal DCs,
peripheral blood DCs and cytokine-derived DCs, as well as
to macrophage subpopulations. The nomenclature used to
define DC subpopulations has evolved with changing
technologies, such that different studies use different
markers to define subpopulations. Dermal DCs have been
identified based on the expression of various cell surface
markers including XCR1+, CD141+, CD1c+, CD1a+ and
CD14+ (3, 21, 47, 56–58), which may vary according to the
method of isolation, digestion vs. migration (55). The analysis
of DC subpopulations in human blood by single cell RNA
sequencing has led to a revised gene-based classification (59).
In reporting the comparison of transcriptomes in LCs to other
cell types, we have maintained the nomenclature in the
original citation.
In comparing LCs to other DC and myeloid cell types, CCL22
was the most frequently detected gene, expressed in seven of the
nine studies and in eight separate comparisons (Figure 2).
CXCL14 was detected as upregulated in six instances in three
LCs transcriptomes (Figure 3). B2M was identified in the
transcriptomes of LCs compared to other cell types in three
different instances (Supplementary Figure S1). GAPDH was
more highly expressed in LCs in two different transcriptomes
(Supplementary Figure S2). CCL27, DEFB1, FURIN, LEAP2,
SNCA, and S100A7 were each identified as preferentially
expressed in LCs in two instances but always in a single LC
transcriptome as compared to other cell types (Supplementary
Table S3). HMGN2 was preferentially expressed in LCs
compared to CD141+ and CD141-CD14- dermal DCs in one
transcriptome (Supplementary Figure S3). SAA2, FAM3A, and
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RARRES2 were identified as upregulated in LCs in one
instance each. Heat maps showing the expression of each gene
in the different transcriptome comparisons are shown in
Supplementary Figures 4–6.
Antimicrobial Genes in LCs Identified in
the Literature
We found corroborating evidence in the literature that four of
the 23 direct antimicrobial genes were expressed in LCs. These
included the CCL17-encoded peptide in cytokine activated LCs
(52), CXCL2 mRNA in freshly isolated LCs (53), CCL22 mRNA
during maturation of LCs (51), and the CCL1-encoded peptide in
epidermal LCs in situ (54). We found reports indicating
expression of eight genes encoding directly antimicrobial
peptides and/or the antimicrobial proteins themselves in
activated LCs that were not detected in any of transcriptomes.
These include CXCL9, CXCL10, CXCL11 (60), POMC (61) and
NPY (62) mRNAs, as well as CAMP, DEFB4 (33) and DEFB103
(63, 64) encoded antimicrobial peptides (Supplementary Table
S4). Thus, a total of 31 antimicrobial genes/proteins were
identified in LCs from analysis of LCs transcriptomes and
published studies.
Cross-Validation of Antimicrobial Genes
Overall, we found that ten of the 23 antimicrobial genes
identified in the LC transcriptomes were cross-validated in at
least two separate studies in the nine LC transcriptomes and/or
four additional published studies. Six of the ten antimicrobial
genes were cross validated by detection in two separate LC
transcriptomes each, in each instance comparing LCs to the
same other DC or myeloid cell type. CXCL14 was upregulated in
LCs vs. blood CD1c+ DCs (Transcriptomes 1 and 2), CCL22 and
GAPDH in LCs vs pDCs (Transcriptomes 2 and T8), and B2M in
LCs compared to different DC populations in Transcriptomes 2
and 6. CCL2 and CCL19 were each upregulated in LCs treated
with TNF for 24 hours vs 0 hours (Transcriptomes 4 and 7).
ADM was upregulated in LCs treated with TNF for 2 hours vs 0
hours (Transcriptomes 4 and 7) and was also more strongly
expressed in LCs vs blood CD1c+ DCs. CCL22 and CXCL2
expression was greater in LCs compared to other cell types in
seven and two different transcriptomes, respectively, and
validated by reverse transcriptase-polymerase chain reaction in
additional studies (51, 53).
We also examined which antimicrobial genes were
differentially expressed in LCs vs keratinocytes (KCs). We
TABLE 1 | Identification of genes encoding peptides with antimicrobial activity in LCs in transcriptome studies.













CCL22 6 7 LCs vs pDCs (T2, T8), LCs vs CD11c+ dermal DCs (T4), LCs vs dermal
MФ (T5), LCs vs CD14+ dermal DCs (T6), LCs vs CD14+ CD1c-
monocyte-derived MФ (T9) and LCs vs monocyte-derived CD14+CD1c
+DCs (T9)
1 [Ross et al.
(51)]
8
CXCL14 3 6 LCs vs CD1c+ mDCs (T1 and T2), LCs vs pDCS (T2), LCs vs Dermal
langerin- cDC2 (T9), LCs vs CD14+ CD1c-monocytederived MФ (T9)
and LCs vs monocyte- derived CD14+CD1c+DCs (T9)
0 N/A 6
ADM 3 4 LCs vs CD1c+ mDCs (T2), LCs vs pDCS (T2), LCs 2h vs 0h (T4, T7) 0 N/A 4
CCL20 2 4 LCs vs moDCs (T1), LCs vs blood CD1c+ mDCs (T1), LCs at 2h vs 0h
(T7), LCs 24h vs 0h (T7)
0 N/A 4
B2M 2 3 LCs vs CD1c+ mDCs (T2), LCs vs CD141+ dermal DCs (T6), LCs vs
CD14+ dermal DCs (T6)
0 N/A 3
CCL17 1 2 LCs 24h vs 0h (T4), LCs 8h vs 0h (T4) 1 [Alferink
et al. (52)]
3
CCL19 2 3 LCs 8h vs 0h (T4), LCs 24h vs 0h (T4, T7) 0 N/A 3
CXCL2 2 2 LCs vs blood CD1c+ mDCs (T1), LCs 2h vs 0h (T7) 1 [Heufler
et al. (53)]
3
CCL1 1 1 LCs 24h vs 0h (T4) 1 [Schaerli
et al. (54)]
2
CCL2 2 2 LCs 24h vs 0h (T4 and T7) 0 N/A 2
CCL27 1 2 LCs vs moDCs (T1), LCs vs blood CD1c+ mDCs (T1), LCs 24h vs 0h,
LCs 8h vs 0h (T4)
0 N/A 2
DEFB1 1 2 LCs vs moDCs (T1), LCs vs blood CD1c+ mDCs (T1) 0 N/A 2
FURIN 1 2 LCs vs pDCs (T8), LCs vs MФ (T8) 0 N/A 2
GAPDH 2 2 LCs vs pDCs (T2 and T8) 0 N/A 2
HMGN2 1 2 LCs vs CD141+ Dermal DCs (T6), LCs vs CD141-CD14- DCs (T6) 0 N/A 2
LEAP2 1 2 LCs vs Dermal CD14+ CD1c+ DCs (T9), LCs vs Dermal Langerin+
cDC2 (T9)
0 N/A 2
S1007A 1 2 LCs vs moDCs (T1), LCs vs blood CD1c+ mDCs (T1) 0 N/A 2
SNCA 1 2 LCs vs moDCs (T1), LCs vs blood CD1c+ mDCs (T1) 0 N/A 2
By mining publicly available data in GEO DataSets, we were able to identify 23 genes encoding antimicrobial peptides that are more strongly expressed in LCs vs. other DC subtypes and/
or in LCs activated with cytokines vs. LCs with no activation. N/A, Not applicable.
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FIGURE 1 | Genes upregulated in LCs after activation with TNF. Boxplots showing the expression of (A) ADM, (B) CCL17, (C) CCL19, (D) CXCL2, (E) CCL2, and
(F) CCL1, encoding antimicrobial peptides in LCs prior to (0h) and at various time points following activation with TNF in transcriptomes 4 and 7. Genes shown
above were identified in at least two instances, either in multiple transcriptomes experiments or in one transcriptome experiment but also identified in LCs in non-
transcriptome experiments in the literature. *p < 0.05, **p < 0.01, ***p < 0.001.
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surveyed GEO DataSets for datasets containing both LCs
and KCs us ing the key t e rms “Langerhans AND
keratinocytes” and found two datasets (GSE168167 and
GSE72104), both data sets containing LCs (n=3) and KCs
(n=2) although our original criteria required n≥3 for each
cell type. We found the expression of CCL22 was greater in
LCs than KCs for both datasets, showing a 6.4- and 3.9-fold
change. In one dataset (GSE72104), CCL17 expression was 4.3-
fold greater in LCs than KCs and was identified in
transcriptome 4 as being upregulated in LCs by TNF at 8
and 24 hours and validated at the protein level in a reporter
mouse (CCL17) (52). CCL1 was identified in a single LC
transcriptome upregulated by TNF after 24 hours and the
protein validated by immunohistochemistry (CCL1) (54).
Using Ingenuity Pathways Analysis, we investigated the
canonical pathways in LCs compared to other cell types,
focusing on the three “Noah’s ark like” instances in which LCs
were compared to the identical cell type in two transcriptomic
studies. Thus, there were two studies each comparing LCs to
pDCs, blood CD1c+ DCs and CD14+ dermal DCs. From the top
100 canonical pathways in each comparison, we identified one
pathway present in all six comparisons and 23 in 5/6
comparisons (Supplementary Table S7), noting that there
were fewer genes and hence pathways identified in LCs vs.
CD14+ dermal DCs from Transcriptome 5. Overall, 21/23
pathways were identified as “signaling” pathways, including
RANK, CD40, CXCR4, IL6 and IL8 signaling, consistent with
the known functional properties of LCs.
FIGURE 2 | CCL22 expression in LCs vs other DC subtypes. CCL22 was preferentially expressed in LCs vs other DC types in 7 out of the 9 transcriptomes in a
total of 8 instances. CCL22 was the most frequently detected gene in transcriptomes and was also previously reported in LCs in non-transcriptome experiments in
the literature. *p < 0.05, **p < 0.01, ***p < 0.001.
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Upstream Regulator Analysis of Genes
Encoding Antimicrobial Proteins in LCs
We used Ingenuity Pathways Analysis and its knowledge
database to identify the predicted upstream regulators of the
31 antimicrobial genes identified in LCs. Of the genes that
encode cytokines, the top upstream regulator was IL1B, (p=
7.07x10-18) (Figure 4). The top 5 upstream regulator genes
encode IL-1b, IFN-g and TNF, all have been reported to
induce one or more of the 30 LC antimicrobial genes in vitro
(52). TNF was identified as the upstream regulator of 20
antimicrobial genes, followed by IFNG as the upstream
regulator of 19 antimicrobial genes and IL1B as the upstream
regulator of 18 antimicrobial genes. Together, the three cytokine
genes were identified as upstream regulators for 25 of the 31
antimicrobial genes (Figure 5). In addition, we examined the
target genes for other top upstream regulators that are known to
contribute to the pathogenesis of skin disease: IL-10 (n=14
downstream genes), IL-22 (n=10), IL-13 (n=9), IL-17A (n=9).
Thus, the antimicrobial gene response would likely be influenced
by the local cytokine environment.
Of the 20 genes predicted to be induced by TNF, we detected
nine genes, ADM, CXCL2, CCL17, CCL27, IL26, CCL19, CCL2,
FIGURE 3 | CXCL14 expression in LCs vs other DC subtypes. CXCL14 was preferentially expressed in LCs vs other DC types in 3 out of the 9 transcriptomes in a
total of 6 different instances. **p < 0.01, ***p < 0.001.
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CCL20 and CCL1 , that were also upregulated in the
transcriptomes of TNF-treated LCs. Of these, CCL17 protein
has been validated to be induced by TNF in vitro (52). Although
the Ingenuity pathways analysis did not predict TNF as an
upstream regulator of CXCL10, TNF induced LCs to secrete
CXCL10 in vitro (65).
Ingenuity pathways analysis identified IL1B as the upstream
regulator for 18 of the 31 antimicrobial genes we identified in LC
transcriptomes and/or the literature. For one these genes, the
IL-1 family member, IL-1a, induces CCL17 encoded peptide in
LCs (52). was validated to induce CCL17 peptide (Alferink et al.,
2003). The addition of IFN-g to LCs leads to the induction of
CAMP and DEFB4 encoded peptides (33), as well as CXCL9,
CXCL10, and CXCL11 mRNAs (60).
Overall, we identified 31 antimicrobial genes in LCs, of which
eight genes were induced by activation with TNF in
transcriptomes, 16 additional genes by comparison of LCs to
other cell types, of which all but one gene were unique, and eight
additional genes were identified in LCs in publications. Of the 31
genes, 12 genes belonged to the chemokine superfamily and
making it the largest family of antimicrobial genes identified in
LCs. Additionally, according to the Antimicrobial Peptide
Database (APD) (35), of the 31 antimicrobial genes identified
in LCs, 29 encode proteins that are antibacterial. Of the 29 genes,
23 encode peptides with activity against gram-positive bacillus
Staphylococcus aureus, which is the leading cause of skin and soft
tissue infections (66–68) (Supplementary Table S6). A total of
18 of the 31 genes encode proteins that are antifungal, six are
antiviral, and five are antiparasitic (Supplementary Table S5).
FIGURE 5 | Antimicrobial network induced by TNF, IFNG and IL1B in LCs. TNF and IFNG were each identified as upstream regulators of 19 antimicrobial genes and
IL1B as the upstream regulator of 18 antimicrobial genes.
FIGURE 4 | Upstream regulation of genes encoding antimicrobial peptides
identified in LCs. Bar graph showing the top 10 upstream regulators ranked
by p value. The top upstream regulator was IL1B (p= 7.07x10-18).
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DISCUSSION
The localization of LCs to the epidermis provides a first line of
defense for the innate immune system to defend the host against
microbial pathogens invading the skin. Surprisingly, few pathways
have been identified by which LCs mediate antimicrobial
responses against viruses (31, 32), bacteria, and fungi (33). Here,
in order to gain insight into the breadth of mechanisms by which
LCs are equipped to mount an antimicrobial response, we
searched publicly available databases for LC transcriptomes and
also reviewed the literature to identify genes which encode
proteins with direct antimicrobial activity against cutaneous
pathogens. Overall, we identified 31 genes encoding proteins
with direct antimicrobial activity, ten of which were identified in
at least two different experiments, thus representing a core set of
genes that comprise the LC antimicrobial gene program. Seven of
these ten antimicrobial genes encode chemokines, CCL1, CCL17,
CCL19, CCL2, CCL22, CXCL14 and CXCL2, which mediate both
antimicrobial and inflammatory responses. CCL22 was identified
in seven of nine transcriptomes in eight total comparisons, as
well as validated in cultured LCs by PCR (51). As such, LCs are
armed with an antimicrobial gene program to combat
microbial pathogens.
Chemokines were the largest family of antimicrobial genes
identified in LCs, accounting for 12 of the 31 genes, including
seven of the ten genes that were cross-validated in at least two
studies. Of the 12 genes, seven belonged to the chemokine
family with a “CC” structure and five to the family with the
“CXC” structure. Chemokines are pro-inflammatory, such
that as part of host defense against microbial pathogens their
trigger the migration of immune cells to the site of infection (69).
However, many chemokines have a dual function, as they possess
direct microbicidal activity (36, 37, 39, 70). Of the chemokines,
CCL22 was the most frequently detected antimicrobial gene,
expressed in six different LC transcriptomes when compared to
other cell types. CCL22 was also previously identified in mature
LCs cocultured with keratinocytes (51). CCL22 is one of the
natural ligands for CCR4, along with CCL17 and CCL2. Both
CCL17 and CCL22 were also upregulated in TNF treated LCs,
with CCL17 protein induced in LCs by TNF in vitro (52).
CCR4 is highly expressed by skin-infiltrating lymphocytes (71)
and is involved in skin homing (72–74) of Th2 T cells, Th17
cells, Th22 cells and Tregs (75–79). LCs, by expression of
CCL22, CCL17, and CCL2 have the potential to recruit a range
of functional CCR4+ T cell subpopulations to the site
of disease.
Three of the top five upstream regulators of the 31
antimicrobial genes detected in LCs, TNF, IL1B and IFNG, have
been corroborated by in vitro studies in which the cytokine was
directly added to LCs. In the two data series in which TNF was
added to activate migratory LCs in vitro, eight antimicrobial genes
were identified (24, 49), all consistent with the TNF-downstream
genes in the Ingenuity knowledge database. TNF is known to
induce the maturation and migration of LCs (19, 80), increasing
the number of LCs (65), and induce the expression of
inflammatory genes in LCs (49, 65, 81).
Of the eight TNF inducible genes in migrating LCs, six encode
chemokines, CCL1, CCL2, CCL17, CCL19 and CCL20, which
along with IL26 were only detected in the transcriptomes of TNF
activated LCs but not in LCs compared to transcriptomes of
other myeloid cell types. Three of these antimicrobial genes have
been corroborated in published papers; CCL1 protein has been
identified in epidermal LCs in situ (54), CCL17 protein in IL-1a
or TNF-activated LCs in vivo in mice (52) and CXCL2mRNA in
freshly isolated murine LC cells (53). In addition to TNF, other
inflammatory stimuli have been reported to induce the
expression of genes in LCs encoding directly antimicrobial
peptides. CAMP and DEFB4 encoded peptides are induced in
LCs by IFN-g (33). CXCL9, CXCL10, and CXCL11 mRNAs are
induced in LCs by stimuli including IFN-g, LPS, and poly I:C (32,
60). NPY mRNA expression in LCs is enhanced by GM-CSF
and LPS (62). In addition, LCs have been shown to express
POMC mRNA upon activation (61). Therefore, the activation
and/or maturation of LCs triggers expression of multiple
antimicrobial genes.
By comparing the expression of antimicrobial genes in LCs to
other cell types, we identified 23 genes that arm LCs with the
capacity to combat cutaneous pathogens and eight additional
genes described in the literature to be expressed by LCs. Of these
31 genes, 23 genes encode peptides with activity against gram-
positive bacillus Staphylococcus aureus, which is the leading
cause of skin and soft tissue infections (66–68). LC expression
of CAMP and DEFB4 results in an antimicrobial activity against
the cutaneous pathogens including M. leprae, S. aureus,
Streptococcus pyogenes and Candida albicans (33). In addition,
LC have been previously shown to mediate an antiviral activity
(32, 82, 83), although the mechanisms involved are not clear.
We previously found that the antimicrobial activity of LCs
leads to killing and subsequent processing of microbial antigens
facilitating antigen presentation to T cells (33). Some of the
antimicrobial peptides expressed by migratory LCs have been
shown to be pro-inflammatory, such as CCL22 and CCL17,
which both act as a chemoattractant for CCR4-expressing T cells
promoting LC:T cell interaction (84). Thus, the ability of LCs, in
particular migratory LCs, to upregulate antimicrobial peptides
links the innate and adaptive immune response, defending the
host against cutaneous pathogens. There are at least two possible
contributions of antimicrobial gene expression in migrating LCs.
We found that ten of the antimicrobial genes expressed in LCs
were cross-validated by various methodologies, identifying a core
set of genes by which LCs can contribute to host defense, that
provide a basis for further functional studies. Any one
antimicrobial gene may be sufficient to mediate an
antimicrobial response, given our published data that IFN-g
upregulation of CAMP was required for antimicrobial activity
in LCs (33). This was demonstrated by knockdown of the CAMP
gene and the use of neutralizing monoclonal antibodies to IFN-g
(33). These strategies provide a strategy to determine whether the
upregulation of multiple antimicrobial genes by cytokines and
cell surface receptors such as Toll-like receptor ligands leads to a
more potent antimicrobial response. It should be possible to
identify key LC pathways that could be leveraged by immune
Oulee et al. Genes Encoding Antimicrobial Proteins in LCs
Frontiers in Immunology | www.frontiersin.org August 2021 | Volume 12 | Article 6953739
therapy augmenting LC antimicrobial responses to combat
cutaneous infection.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in
the article/Supplementary Material. Further inquiries can be
directed to the corresponding author.
AUTHOR CONTRIBUTIONS
Conceptualization: AO and RM. Data curation: AH and JR.
Formal analysis: AO, RM, RT, FM, and EK. Funding acquisition:
RM. Investigation: AO and RM. Methodology: AO and RM.
Project administration: AO and RM. Resources: RM, FM, and
MP. Software: FM and MP. Supervision: RM. Validation: EK.
Visualization: AO and RM. Writing—original draft preparation:
AO and RM. Writing—review and editing: AO, RM, AH, RT,
FM, and BA. All authors contributed to the article and approved
the submitted version.
FUNDING
NIH grants R01 AI022553 (RLM, MP), R01 AR040312 (RLM,
MP), R01 AR073252 (RLM, MP), R01 AR074302 (RLM, MP),
NHMRCIdeas Grant APP1181482 (AH), 5R21EB024767-02
(EK), 1R01AR075959-01 (EK) and 1R01CA245277-01A1 (EK).
SUPPLEMENTARY MATERIAL




1. Banchereau J, Steinman RM. Dendritic Cells and the Control of Immunity.
Nature (1998) 392:245–52. doi: 10.1038/32588
2. Klechevsky E, Banchereau J. Human Dendritic Cells Subsets as Targets and
Vectors for Therapy. Ann N Y Acad Sci (2013) 1284:24–30. doi: 10.1111/
nyas.12113
3. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, et al.
Functional Specializations of Human Epidermal Langerhans Cells and CD14
+ Dermal Dendritic Cells. Immunity (2008) 29(3):497–510. doi: 10.1016/
j.immuni.2008.07.013
4. Banchereau J, Zurawski S, Thompson-Snipes L, Blanck JP, Clayton S, Munk
A, et al. Immunoglobulin-Like Transcript Receptors on Human Dermal
CD14+ Dendritic Cells Act as a CD8-Antagonist to Control Cytotoxic T
Cell Priming. Proc Natl Acad Sci USA (2012) 109(46):18885–90. doi: 10.1073/
pnas.1205785109
5. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T, et al. Dendritic
Cell Subsets in Health and Disease. Immunol Rev (2007) 219:118–42.
doi: 10.1111/j.1600-065X.2007.00551.x
6. Korenfeld D, Gorvel L, Munk A, Man J, Schaffer A, Tung T, et al. A Type of
Human Skin Dendritic Cell Marked by CD5 Is Associated With the
Development of Inflammatory Skin Disease. JCI Insight (2017) 2(18).
doi: 10.1172/jci.insight.96101
7. Bertram KM, Botting RA, Baharlou H, Rhodes JW, Rana H, Graham JD, et al.
Identification of HIV Transmitting CD11c(+) Human Epidermal Dendritic
Cells. Nat Commun (2019) 10(1):2759. doi: 10.1038/s41467-019-10697-w
8. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y,
et al. Langerin, a Novel C-Type Lectin Specific to Langerhans Cells, is an
Endocytic Receptor That Induces the Formation of Birbeck Granules.
Immunity (2000) 12(1):71–81. doi: 10.1016/s1074-7613(00)80160-0
9. Fithian E, Kung P, Goldstein G, Rubenfeld M, Fenoglio C, Edelson R.
Reactivity of Langerhans Cells With Hybridoma Antibody. Proc Natl Acad
Sci USA (1981) 78(4):2541–4. doi: 10.1073/pnas.78.4.2541
10. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External Antigen
Uptake by Langerhans Cells With Reorganization of Epidermal Tight
Junction Barriers. J Exp Med (2009) 206(13):2937–46. doi: 10.1084/
jem.20091527
11. Osorio F, Reis e Sousa C. Myeloid C-Type Lectin Receptors in Pathogen
Recognition and Host Defense. Immunity (2011) 34(5):651–64. doi: 10.1016/
j.immuni.2011.05.001
12. de Jong MA, Geijtenbeek TB. Langerhans Cells in Innate Defense Against
Pathogens. Trends Immunol (2010) 31(12):452–9. doi: 10.1016/
j.it.2010.08.002
13. Nasr N, Lai J, Botting RA, Mercier SK, Harman AN, Kim M, et al. Inhibition
of Two Temporal Phases of HIV-1 Transfer From Primary Langerhans Cells
to T Cells: The Role of Langerin. J Immunol (2014) 193(5):2554–64.
doi: 10.4049/jimmunol.1400630
14. Kashem SW, Haniffa M, Kaplan DH. Antigen-Presenting Cells in the Skin.
Annu Rev Immunol (2017) 35(1):469–99. doi: 10.1146/annurev-immunol-
051116-052215
15. Klechevsky E. Functional Diversity of Human Dendritic Cells. Adv Exp Med
Biol (2015) 850:43–54. doi: 10.1007/978-3-319-15774-0_4
16. Merad M, Ginhoux F, Collin M. Origin, Homeostasis and Function of
Langerhans Cells and Other Langerin-Expressing Dendritic Cells. Nat Rev
Immunol (2008) 8(12):935–47. doi: 10.1038/nri2455
17. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn
JM. Migration and Maturation of Langerhans Cells in Skin Transplants and
Explants. J Exp Med (1990) 172(5):1483–93. doi: 10.1084/jem.172.5.1483
18. Harman AN, Wilkinson J, Bye CR, Bosnjak L, Stern JL, Nicholle M, et al. HIV
Induces Maturation of Monocyte-Derived Dendritic Cells and Langerhans
Cells. J Immunol (2006) 177(10):7103–13. doi: 10.4049/jimmunol.177.10.7103
19. Kimber I, Cumberbatch M. Stimulation of Langerhans Cell Migration by
Tumor Necrosis Factor Alpha (TNF-Alpha). J Invest Dermatol (1992) 99
(5):48s–50s. doi: 10.1111/1523-1747.ep12668986
20. Wang B, Amerio P, Sauder DN. Role of Cytokines in Epidermal
Langerhans Cell Migration. J Leukoc Biol (1999) 66(1):33–9. doi: 10.
1002/jlb.66.1.33
21. Artyomov MN, Munk A, Gorvel L, Korenfeld D, Cella M, Tung T, et al.
Modular Expression Analysis Reveals Functional Conservation Between
Human Langerhans Cells and Mouse Cross-Priming Dendritic Cells. J Exp
Med (2015) 212(5):743–57. doi: 10.1084/jem.20131675
22. Wu X, Briseño CG, Durai V, Albring JC, Haldar M, Bagadia P, et al. Mafb
Lineage Tracing to Distinguish Macrophages From Other Immune Lineages
Reveals Dual Identity of Langerhans Cells. J Exp Med (2016) 213(12):2553–65.
doi: 10.1084/jem.20160600
23. Banchereau J, Thompson-Snipes L, Zurawski S, Blanck J-P, Cao Y, Clayton S,
et al. The Differential Production of Cytokines by Human Langerhans Cells
and Dermal CD14(+) DCs Controls CTL Priming. Blood (2012) 119
(24):5742–9. doi: 10.1182/blood-2011-08-371245
24. Sirvent S, Vallejo AF, Davies J, Clayton K, Wu Z, Woo J, et al. Genomic
Programming of IRF4-Expressing Human Langerhans Cells. Nat Commun
(2020) 11(1):313. doi: 10.1038/s41467-019-14125-x
25. Balin SJ, Pellegrini M, Klechevsky E, Won ST, Weiss DI, Choi AW, et al.
Human Antimicrobial Cytotoxic T Lymphocytes, Defined by NK Receptors
and Antimicrobial Proteins, Kill Intracellular Bacteria. Sci Immunol (2018) 3
(26). doi: 10.1126/sciimmunol.aat7668
Oulee et al. Genes Encoding Antimicrobial Proteins in LCs
Frontiers in Immunology | www.frontiersin.org August 2021 | Volume 12 | Article 69537310
26. Penel-Sotirakis K, Simonazzi E, Peguet-Navarro J, Rozieres A. Differential
Capacity of Human Skin Dendritic Cells to Polarize CD4+ T Cells Into IL-17,
IL-21 and IL-22 Producing Cells. PloS One (2012) 7(11):e45680. doi: 10.1371/
journal.pone.0045680
27. Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG. Human
Langerhans Cells Induce Distinct IL-22-Producing CD4+ T Cells Lacking IL-
17 Production. Proc Natl Acad Sci USA (2009) 106(51):21795–800.
doi: 10.1073/pnas.0911472106
28. Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA.
Recognition of Cluster of Differentiation 1 Antigens by Human CD4-CD8-
Cytolytic T Lymphocytes. Nature (1989) 341:447–50. doi: 10.1038/341447a0
29. de Jong A, Cheng TY, Huang S, Gras S, Birkinshaw RW, Kasmar AG, et al.
CD1a-Autoreactive T Cells Recognize Natural Skin Oils That Function as
Headless Antigens. Nat Immunol (2014) 15(2):177–85. doi: 10.1038/ni.2790
30. Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH, et al.
Langerhans Cells Utilize CD1a and Langerin to Efficiently Present
Nonpeptide Antigens to T Cells. J Clin Invest (2004) 113(5):701–8.
doi: 10.1172/jci19655
31. van der Vlist M, Geijtenbeek TB. Langerin Functions as an Antiviral Receptor
on Langerhans Cells. Immunol Cell Biol (2010) 88(4):410–5. doi: 10.1038/
icb.2010.32
32. Renn CN, Sanchez DJ, Ochoa MT, Legaspi AJ, Oh CK, Liu PT, et al. TLR
Activation of Langerhans Cell-Like Dendritic Cells Triggers an Antiviral
Immune Response. J Immunol (2006) 177(1):298–305. doi: 10.4049/
jimmunol.177.1.298
33. Dang AT, Teles RM, Liu PT, Choi A, Legaspi A, Sarno EN, et al. Autophagy
Links Antimicrobial Activity With Antigen Presentation in Langerhans Cells.
JCI Insight (2019) 4(8):e126955. doi: 10.1172/jci.insight.126955
34. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI Gene
Expression and Hybridization Array Data Repository. Nucleic Acids Res
(2002) 30(1):207–10. doi: 10.1093/nar/30.1.207
35. Wang G, Li X, Wang Z. APD3: The Antimicrobial Peptide Database as a Tool
for Research and Education. Nucleic Acids Res (2016) 44(D1):D1087–93.
doi: 10.1093/nar/gkv1278
36. Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, et al. The
Structure of Human Macrophage Inflammatory Protein-3alpha/CCL20.
Linking Antimicrobial and CC Chemokine Receptor-6-Binding Activities
With Human Beta-Defensins. J Biol Chem (2002) 277(40):37647–54.
doi: 10.1074/jbc.M203907200
37. Kotarsky K, Sitnik KM, Stenstad H, Kotarsky H, Schmidtchen A, Koslowski
M, et al. A Novel Role for Constitutively Expressed Epithelial-Derived
Chemokines as Antibacterial Peptides in the Intestinal Mucosa. Mucosal
Immunol (2010) 3(1):40–8. doi: 10.1038/mi.2009.115
38. Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, et al.
Thrombocidins, Microbicidal Proteins From Human Blood Platelets, are C-
Terminal Deletion Products of CXC Chemokines. J Biol Chem (2000) 275
(27):20374–81. doi: 10.1074/jbc.275.27.20374
39. Burkhardt AM, Tai KP, Flores-Guiterrez JP, Vilches-Cisneros N, Kamdar K,
Barbosa-Quintana O, et al. CXCL17 is a Mucosal Chemokine Elevated in
Idiopathic Pulmonary Fibrosis That Exhibits Broad Antimicrobial Activity.
J Immunol (2012) 188(12):6399–406. doi: 10.4049/jimmunol.1102903
40. Strbo N, Pastar I, Romero L, Chen V, Vujanac M, Sawaya AP, et al. Single Cell
Analyses Reveal Specific Distribution of Anti-Bacterial Molecule Perforin-2 in
Human Skin and its Modulation by Wounding and Staphylococcus Aureus
Infection. Exp Dermatol (2019) 28(3):225–32. doi: 10.1111/exd.13870
41. Dhiman R, Venkatasubramanian S, Paidipally P, Barnes PF, Tvinnereim A,
Vankayalapati R. Interleukin 22 Inhibits Intracellular Growth of
Mycobacterium Tuberculosis by Enhancing Calgranulin A Expression.
J Infect Dis (2014) 209(4):578–87. doi: 10.1093/infdis/jit495
42. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK.
Antimicrobial Actions of Calcium Binding Leucocyte L1 Protein, Calprotectin.
Lancet (1990) 336(8718):763–5. doi: 10.1016/0140-6736(90)93237-j
43. Oliveros JC. Venny 2.1.0. (2007).
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